109 related articles for article (PubMed ID: 11697541)
21. Effects of various absorption enhancers on the intestinal absorption of water soluble drugs by in vitro Ussing chamber method: correlation with an in situ absorption experiment.
Sugiyama T; Yamamoto A; Kawabe Y; Uchiyama T; Quan YS; Muranishi S
Biol Pharm Bull; 1997 Jul; 20(7):812-4. PubMed ID: 9255426
[TBL] [Abstract][Full Text] [Related]
22. Regional delivery of model compounds and 5-Fluorouracil to the liver by their application to the liver surface in rats: its implication for clinical use.
Nishida K; Fujiwara R; Kodama Y; Fumoto S; Mukai T; Nakashima M; Sasaki H; Nakamura J
Pharm Res; 2005 Aug; 22(8):1331-7. PubMed ID: 16078143
[TBL] [Abstract][Full Text] [Related]
23. Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells.
Ikemura K; Urano K; Matsuda H; Mizutani H; Iwamoto T; Okuda M
J Pharmacol Exp Ther; 2009 Jan; 328(1):249-55. PubMed ID: 18842703
[TBL] [Abstract][Full Text] [Related]
24. Effect of intestinal atrophy and hepatic impairment induced by parenteral nutrition on drug absorption and disposition in rats.
Fukushima K; Miki T; Nakamoto K; Nishimura A; Koyama H; Ichikawa H; Shibata N; Tokuyama S; Sugioka N
JPEN J Parenter Enteral Nutr; 2015 Feb; 39(2):218-27. PubMed ID: 23894177
[TBL] [Abstract][Full Text] [Related]
25. Estimation of absorption enhancement by medium-chain fatty acids in rat large intestine.
Higaki K; Yata T; Sone M; Ogawara K; Kimura T
Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):231-40. PubMed ID: 11758652
[TBL] [Abstract][Full Text] [Related]
26. Absorption of phenolsulfonphthalein as a model across the mesenteric surface in rats to determine the drug absorption route after intraperitoneal administration.
Nishida K; Nose S; Kuma A; Mukai T; Nakashima M; Sasaki H; Nakamura J
J Pharm Pharmacol; 2004 May; 56(5):683-7. PubMed ID: 15142348
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness and toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and protein and phospholipid release from the intestinal membrane.
Uchiyama T; Yamamoto A; Hatano H; Fujita T; Muranishi S
Biol Pharm Bull; 1996 Dec; 19(12):1618-21. PubMed ID: 8996651
[TBL] [Abstract][Full Text] [Related]
28. Intestinal first-pass effect of bumetanide in rats.
Kim EJ; Han KS; Lee MG
Int J Pharm; 2000 Jan; 194(2):193-9. PubMed ID: 10692643
[TBL] [Abstract][Full Text] [Related]
29. Time-dependent effects on small intestinal transport by absorption-modifying excipients.
Dahlgren D; Roos C; Lundqvist A; Tannergren C; Sjöblom M; Sjögren E; Lennernäs H
Eur J Pharm Biopharm; 2018 Nov; 132():19-28. PubMed ID: 30179738
[TBL] [Abstract][Full Text] [Related]
30. Human oral drugs absorption is correlated to their in vitro uptake by brush border membrane vesicles.
Oulianova N; Cheng D; Huebert N; Chen Y
Int J Pharm; 2007 May; 336(1):115-21. PubMed ID: 17178445
[TBL] [Abstract][Full Text] [Related]
31. Intestinal transport and metabolism of analgesic dipeptide, kyotorphin: rate-limiting factor in intestinal absorption of peptide as drug.
Mizuma T; Koyanagi A; Awazu S
Biochim Biophys Acta; 1997 Apr; 1335(1-2):111-9. PubMed ID: 9133647
[TBL] [Abstract][Full Text] [Related]
32. An in vitro perfusion model for the determination of absorption properties of drugs in isolated rat small intestine.
Norta M; Schöpke T
Pharmazie; 1996 Feb; 51(2):101-3. PubMed ID: 8720805
[TBL] [Abstract][Full Text] [Related]
33. Improved stomach selectivity of gene expression following microinstillation of plasmid DNA onto the gastric serosal surface in mice.
Nishi J; Fumoto S; Ishii H; Kodama Y; Nakashima M; Sasaki H; Nakamura J; Nishida K
Eur J Pharm Biopharm; 2008 Jun; 69(2):633-9. PubMed ID: 18222072
[TBL] [Abstract][Full Text] [Related]
34. Standardization of an ex vivo method for determination of intestinal permeability of drugs using everted rat intestine apparatus.
Dixit P; Jain DK; Dumbwani J
J Pharmacol Toxicol Methods; 2012 Jan; 65(1):13-7. PubMed ID: 22107724
[TBL] [Abstract][Full Text] [Related]
35. The transport of the lead cation across the intestinal membrane.
Blair JA; Coleman IP; Hilburn ME
J Physiol; 1979 Jan; 286():343-50. PubMed ID: 439029
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of mucosal damage and recovery in the gastrointestinal tract of rats by a penetration enhancer.
Narkar Y; Burnette R; Bleher R; Albrecht R; Kandela A; Robinson JR
Pharm Res; 2008 Jan; 25(1):25-38. PubMed ID: 18161013
[TBL] [Abstract][Full Text] [Related]
37. Effect of selective cyclooxygenase-2 inhibitor lumiracoxib on phenolsulfonphthalein disposition in rats.
Honjo H; Uwai Y; Nabekura T
Drug Metabol Drug Interact; 2014; 29(3):203-6. PubMed ID: 24870608
[TBL] [Abstract][Full Text] [Related]
38. Small intestinal fluid absorption in the rat during haemorrhage and its importance for plasma refill.
Redfors S
Acta Physiol Scand; 1987 Nov; 131(3):429-37. PubMed ID: 3425347
[TBL] [Abstract][Full Text] [Related]
39. Intestinal absorption and biliary secretion of zinc in rats with chronic renal failure.
Chen SM; Liao JF; Kuo CD; Ho LT
Nephron Physiol; 2004; 96(4):p113-20. PubMed ID: 15122057
[TBL] [Abstract][Full Text] [Related]
40. Absorption of N4-D-glucopyranosylsulphamethazine by rat everted intestinal sacs.
Wang Y; Grigg R; McCormack A; Symonds H; Bowmer C
Biochem Pharmacol; 1993 Nov; 46(10):1864-6. PubMed ID: 8250974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
